Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues
- PMID: 6779327
- DOI: 10.1007/BF00433256
Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues
Abstract
Rats were treated continuously with haloperidol (1.5 mg/kg/day in drinking water) for 3 1/2 months. Prior to withdrawal of neuroleptic both spontaneous activity and stereotypy responses to a low dose of apomorphine (0.15 mg/kg SC) were significantly reduced. Thus these indices of dopamine receptor blockade did not show tolerance or adaptation. When these measures were repeated shortly after haloperidol withdrawal stereotypy responses of the control group were indistinguishable from their responses on initial testing while haloperidol-withdrawn animals showed substantially more intense responsivity than on their initial assessment; the stereotypy responses of haloperidol-withdrawn animals were indistinguishable from parallel control values at 10--20 min after apomorphine challenge but were significantly above control values at 30--40 min after challenge. Control animals showed habituation of locomotor activity in the motility monitor when measures on the first and second assessments were compared while haloperidol animals showed indistinguishable activities on each assessment. Such methodological epiphenomena may influence the interpretation of studies on the functional sequelae of prolonged neuroleptic treatment and its subsequent withdrawal in the rat.
Similar articles
-
Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.Gen Pharmacol. 1984;15(4):363-5. doi: 10.1016/0306-3623(84)90017-x. Gen Pharmacol. 1984. PMID: 6541605
-
Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.Biol Psychiatry. 1982 Nov;17(11):1289-301. Biol Psychiatry. 1982. PMID: 6891268
-
Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.Eur J Pharmacol. 1982 Jun 16;81(1):1-9. doi: 10.1016/0014-2999(82)90595-7. Eur J Pharmacol. 1982. PMID: 6889533
-
Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administration.Eur J Pharmacol. 1980 Oct 31;67(4):363-9. doi: 10.1016/0014-2999(80)90177-6. Eur J Pharmacol. 1980. PMID: 7192633
-
Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.Addict Biol. 2009 Jul;14(3):283-93. doi: 10.1111/j.1369-1600.2008.00145.x. Epub 2009 Mar 5. Addict Biol. 2009. PMID: 19298320
Cited by
-
Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378(1):117-24. doi: 10.1007/s00210-008-0283-x. Epub 2008 Apr 12. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18408917
-
The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.Psychopharmacology (Berl). 1984;82(4):371-7. doi: 10.1007/BF00427688. Psychopharmacology (Berl). 1984. PMID: 6427831
-
Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5-HT2A receptors in rats.Neuropsychopharmacol Rep. 2019 Dec;39(4):279-288. doi: 10.1002/npr2.12076. Epub 2019 Sep 5. Neuropsychopharmacol Rep. 2019. PMID: 31487433 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources